










Clinical features and outcome of patients with severe 
lower respiratory tract infection admitted to a Paediatric 
Intensive Care Unit in the Western Cape, South Africa. 
Master of Medicine in Paediatrics 
Dr Hayley Hutton 
Faculty of Health Sciences, University of Cape Town 
HTTHAY001 
Supervisors:
Professor Heather J Zar:
Head of Department of Paediatrics and Child Health, The Red Cross War Memorial Children’s 
Hospital, Director of MRC Unit on Child & Adolescent Health:
Professor Andrew Argent:
Head of the Paediatric Intensive Care Unit, The Red Cross War Memorial Children’s Hospital.
Submitted February 2016 
The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
Published by the University of Cape Town (UCT) in terms 

















Chapter 1: Literature review 
 Introduction……………………………………………………………………………………..8 
 Methods: Search strategy…………………………………………………………………….8 
 Review of the literature………………………………………………………………………..9 
 Conclusions…………………………………………………………………………………….17 
 References……………………………………………………………………………………..19 
Chapter 2: Study Protocol 
 Study aim……………………………………………………………………………………….28 
 Study objective…………………………………………………………………………………28 
 Methodology……………………………………………………………………………………29 
 Research procedures and data collection…………………………………………………..30 
 Time frame……………………………………………………………………………………..32 
 Description of risks and benefits……………………………………………………………..32 
 Dissemination of data…………………………………………………………………………33 
 Ethical considerations…………………………………………………………………………33 
Chapter 3: Publication ready manuscript…………………………………………………………….35 
Appendix A: Definitions………………………………………………………………………………...61 
Appendix B: Standardised interpretation of paediatric chest radiographs………………………..63 
Appendix C: Data capture form………………………………………………………………………..64 
Appendix D: Ethics approval………………………………………………………(see attached PDF) 
Appendix E: Instruction to authors: Pediatric Critical Care Medicine…………(see attached PDF) 
3 
Declaration 
I, Hayley Kathryn Hutton, declare that the dissertation reported is based on independent work 
performed by myself (except where acknowledgements indicate otherwise) and that neither the 
whole work nor any part of it has been, is being, or is to be submitted for another degree to any 
other university.  I declare that this work has not been reported or published prior to registration 
for the abovementioned degree. 
I empower the University of Cape Town to reproduce for the purpose of research either the 
whole or any portion of the contents in any manner whatsoever. 
Signed: ______ _____________________________________________ 






Objective: Acute lower respiratory tract infection (ALRTI) remains an important cause of 
childhood morbidity and mortality in low and middle income countries (LMIC). This study aims to 
describe the clinical features of children admitted to a Pediatric Intensive Care Unit (PICU) with 
severe ALRTI and to investigate risk factors, clinical course and in-hospital outcome.    
Design: Retrospective cohort study  
Setting: Red Cross War Memorial Children’s Hospital, Cape Town, South Africa 
Patients: 265 children (0-12years) admitted to the PICU during 2012 with a primary diagnosis 
of ALRTI. 
Intervention: None. 
Measurements and main results: 265 patients [median (interquartile range, IQR) age 4 
months (2-12months)] were admitted with ALRTI, 157(59.3%) were male. Co-morbid disease 
was present in 102(38.5%) including cardiac disease in 42(15.9%) or tuberculosis in 7(6.4%) . 
While only 27(10.2%) were HIV infected, 87(32.8%) children were HIV exposed.   
The in-hospital mortality was 34(12.8%); 24(9.1%) died in PICU and a further 10 in the medical 
wards following discharge from PICU.  The median duration of ICU and hospital stay was 4.0 
days (2.0-8.0) and 12.5 days (7.9-28.0) respectively. Most [192 (72.5%)] children required 
invasive ventilatory support, while 42 (15.8%) patients required cardiac inotropic support. 
Risk factors for mortality included severe malnutrition (Odds ratio (OR) 8.25; 95% CI 1.47-
46.21); informal housing without access to piped water and/or electricity (OR11.87; CI 1.89-
20.81); or need for inotropic support (OR 44.35; CI 8.20-239.92). HIV exposure or infection was 
associated with a significantly longer duration of hospital stay (p=0.002). 
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Conclusion: Severe ALRTI occurs predominantly in young infants and is associated with a high 
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Pneumonia is a leading cause of death in children under the age of five years, placing a 
considerable burden on health and economic resources in Low and Middle income countries 
(LMIC).1 The World Health Organisation (WHO) recognises that pneumonia is the major cause 
of severe or very severe acute lower respiratory tract infections (ALRTI) and is responsible for 
up to 18% of deaths in children under the age of five years2,3,4. Severe ALRTI carry a substantial 
risk of morbidity and mortality and places a large burden on the family, the health system and 
the scarce resources of countries.  With the development of the Millennium Development Goals 
there has been renewed interest and vigour in tackling some of the major burdens of childhood 
illness in attempt to improve childhood mortality. A better understanding of the impact of severe 
ALRTI as well as an understanding of the particular risk factors, aetiology and outcomes may 
inform improvements in intervention programmes and management strategies.  The objective in 
this descriptive review is to determine current understanding and depth of knowledge of severe 
ALRTI in terms of the extent of the burden of disease; an understanding of those factors that 
place children at risk and the clinical features that may be helpful in understanding the 
outcomes and survival rates of those children admitted to hospitals with severe ALRTI.   
 
Methods: Search Strategy   
 
My search strategy of the literature was carried out during the months of May/June 2013 and 
involved computer based searches using four major search engines including Pubmed, Medline, 
Cochrane databases and Google Scholar.  Medical subject headings(MeSH) were used to 
search the databases.  The population of interest was children under the age of 12.  Search 
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terms used included, “child OR infant OR neonate.”  ALRTI were described using the MeSH, 
“pneumonia OR bronchopneumonia OR respiratory tract infections OR pneumonia, viral OR 
bronchiolitis OR Respiratory Syncytial Virus OR CMV OR tuberculosis, pulmonology.”  These 
articles were limited to English articles published after 1990 for practical purposes and to ensure 
only recent studies were included.  The focus of the review included research performed in 
LMIC and was restricted to severe ALRTI’s. 
 
Review of the literature 
 
Pneumonia is the major cause of severe or very severe ALRTI and the most important cause of 
mortality in the paediatric population especially in Sub Saharan Africa.5   In South Africa and the 
Western Cape, data from the Childhood Problem Identification Program in 2009 showed that 
pneumonia is one of the leading causes of death in hospital in children under the age of 5 years 
(29% and 18% respectively.)6   Severe and very severe pneumonia are defined according to the 
WHO standards.7 (see Appendix A).  Current estimates are that pneumonia causes 1.3 million 
deaths in children under 5 years of age annually.3 WHO estimated 19.2 million cases of severe 
acute lower respiratory tract infection (ALRTI)4 and 3 million cases of very severe ALRTI 
worldwide in 2010 with 62% treated in a hospital setting. The in-hospital case fatality rate is 
estimated by WHO to be between 2.3 and 6% depending on severity of disease.4  A large 
proportion of children with ALRTI’s still do not have access to hospitals and therefore most 
deaths related to ALRTI’s occur in the communities (81% of all deaths associated with 
respiratory tract infection occur outside of the hospital).4  
 
It is not well understood what proportion of children presenting with an ALRTI will require 
admission to a Paediatric Intensive Care Unit (PICU) and outcomes vary substantially in 
different regions.  A recent study in China suggested that 7% of children with ALRTI needed 
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intensive care with an average length of stay of 5 days; 21 % of children required mechanical 
ventilation.  The case fatality rate was 5.8%.8  A retrospective multicentre analysis in low and 
middle income countries (LMIC) conducted during the peak respiratory seasons did not report 
an admission rate to the PICU.  However, 55% of children admitted to the PICU required 
invasive ventilation with a median duration of PICU stay of 10 days.  The case fatality rate in 
these children was 13%.9  
 
In South Africa and the Western Cape, data from the Childhood Problem Identification Program 
in 2009 showed that ALRTI including pneumonia is one of the leading causes of death in 
hospital in children under the age of 5 years (29% and 18% respectively.)6   A study done in 
1998 at Red Cross War Memorial Children’s Hospital (RCWMCH) of HIV infected and 
uninfected children admitted to PICU with pneumonia reported a mortality rate of 29% and 14% 
respectively.10  Importantly this study preceded the roll out of antiretroviral therapy for children, 
so none of the HIV-infected children were on highly active antiretroviral therapy (HAART).  The 
case fatality rate for severe pneumonia in a PICU in Pretoria was reported to be 30% a decade 
ago.11  More recent work done to investigate the outcome of severe viral ALRTI in the PICU at 
RCWMCH reported a case fatality rate of 11%.12  The limited South African data suggests a 
much higher case fatality rate than those reported by the WHO4 and highlights the need for a 
better understanding of the risk factors and aetiological agents involved that influence survival. 
 
Aetiology of severe ALRTI 
 
Defining the aetiology of ALRTI is challenging. Blood cultures have a notoriously low yield 
ranging from 3-20%, with higher rates reported for HIV-infected children.13,14 Sputum samples 
have a far better yield (54%) for bacteria but it is difficult to distinguish colonizing organisms 
from those that may be pathogenic for ALRTI.13,14   The advent of multiplex PCR testing for 
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respiratory viruses, bacteria and other organisms has dramatically increased the yield of 
potential aetiological organisms  from nasopharyngeal aspirates; however it is challenging to 
distinguish colonizing organisms from those causing ALRTI.15  Respiratory viruses such as 
Respiratory Syncytial Virus(RSV), Rhinovirus, Influenza, Adenovirus and Human 
Metapneumovirus in the PICU may be associated with severe disease and high mortality rates 
in South Africa.12  In 2002, a report of a hospital outbreak at RCWMCH of severe ALRTI caused 
by Adenovirus showed that 45% of those children who contracted the virus in hospital required 
admission to the PICU.  39% of those patients required ventilatory support with a mean duration 
of stay in the PICU of 6.5 days and a PICU mortality rate of 23%.16  RSV and Human 
Metapneumovirus are associated with mortality rates of 15 and 18% respectively.17  It is 
important however to note that between 40-68% of asymptomatic children will have a virus 
detected on an upper respiratory tract swab.18    
Other organisms such as Cytomegalovirus, Pneumocystis jiroveci, atypical bacteria and 
Mycobacterium tuberculosis, may also be important in the aetiology of ALRTI in the South 
African setting.19,20,21,22,23,24  Accumulating evidence suggests that severe ALRTI is usually due to 
polymicrobial infections including bacterial-viral, bacterial-mycobacterial, viral-viral thus making 
aetiological diagnosis even more challenging.22,23,24,25 
 
Risk factors for severe ALRTI 
 
Several factors can predispose children to ALRTI and to severe disease.  Risk factors include 
age less than 1 year8,26 (in South Africa, children less than 10 weeks of age are at greatest risk 
for respiratory tract infection.11); prematurity (gestational age of 32-36 week) and low birth 
weight of <2.5kg27,28,29; severe or moderate malnutrition according to WHO classification 30, 
micronutrient deficiency and comorbid disease (especially congenital cardiac disease31 and 
immunosuppressive disease especially in the form of HIV disease17).  A distinct seasonal 
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variation is well described internationally.26,32  In South Africa common respiratory viruses show 
distinct peaks in early winter and early spring.12 Overcrowding, parental smoking and exposure 
to indoor air pollution places infants and children at higher risk of pneumonia.26,33,34,35  In the 
South African context, HIV-infection or exposure may be one of the most important risk factors 
for severe ALRTI.  Nosocomial acquired ALRTI are associated with increased severity of 
disease and increased mortality.36,37 
 
A protective factor that was identified in many of the studies worldwide is exclusive 
breastfeeding for 6 months.  The protection wanes as the infant gets older but in the first year of 
life exclusive breastfeeding can halve the risk of ALRTI.38 
 
In the South African context, management of ALRTI is made more complex by a high burden of 
comorbidity. The incidence of malnutrition and TB, at 34% and 7% respectively6 has a 
significant negative impact on the health of our children.  More importantly however is the high 
prevalence of HIV disease and its associated complications. The high burden of HIV disease in 
the paediatric population severely impacts not only the outcomes of ALRTI but the incidence, 
aetiology, the clinical presentation, the severity and the efficacy of management of those 
infections.39 
 
HIV-infected children have an increased risk of severe ALRTI increased incidence of 
opportunistic respiratory infections, and a worse outcome than HIV uninfected patients.39 
Opportunistic infections are common in children with HIV infections with diseases of the 
respiratory tract being the most common site of infections.40   Children who are HIV infected are 
at higher risk of contracting community acquired ALRTI often with a more severe clinical course.  
The presentation of the ALRTI is more severe41 or shows atypical radiological features42 with 
decreased response to empiric treatment43 The aetiological agents in HIV infected patients 
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include a wider range of pathogens and mixed infections44 which could contribute to the poor 
response to empiric treatment.  Atypical and Gram negative organisms, Pneumocystis jirovecii 
and Cytomegalovirus are being recognised as more important opportunistic respiratory 
pathogens in LMIC countries, in keeping with international data.20,40,43 However, use of HAART 
especially when initiated early in the course of HIV infection and of CTX prophylaxis has 
dramatically reduced the risk of pneumonia and severe  
pneumonia.45 Mycobacterium tuberculosis remains an important cause of ALRTI in children in 
areas of high TB incidence. 24,46    
 
An initial study to investigate the aetiology, associated features and outcomes of pneumonia in 
HIV infected and uninfected children at RCWMCH highlighted the importance of Pneumocystis 
jirovecii as a pathogen.10  Over half of the children enrolled in this were HIV infected (60,4%; 
95% confidence interval 54,2-66,3%); ALRTI was the presenting clinical feature of HIV in 
approximately a quarter of children.  The outcomes of HIV infected children were notably worse 
with a mortality rate of 22,5% in comparison to 8,1% of their HIV uninfected counterparts.  
Pneumocystis jirovecii made a considerable contribution to this difference in mortality and was 
the only significant risk factor for mortality in HIV infected children. 
This study encouraged policy development with regards to Pneumocystis jirovecii prophylaxis, 
diagnostics in children with ALRTI and more aggressive treatment and preventative strategies 
for children suspected of being HIV infected.  It also brought to question the ethical challenges 
of policy guidelines around the admission of HIV infected children to the PICU.  
 
In the era of successful mother to child prevention programs, a uniquely vulnerable group, the 
HIV-exposed uninfected child is emerging.  In the Western cape 21% of women presenting to 
antenatal clinics are HIV infected with mother to child transmission rates currently recorded at 
3.9%, therefore there are few HIV-infected children but a considerable number of HIV-exposed 
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uninfected children.47  Increasing evidence suggest that HIV-exposed uninfected children may 
have some immune compromise with a higher risk for ALRTI and opportunistic infections than 
unexposed children.   
Changes in the immune system of HIV-exposed uninfected infants are beginning to be 
described.  A review article reported that in utero exposure to the HIV virus results in altered 
cellular immune responses.48 The underlying mechanisms of the altered immune responses 
remains unclear.  In Brazil, a group of HIV-exposed uninfected infants followed up for 6 months 
showed an overall increased incidence of infections with 1.8 infections per infant.  The most 
common infections were skin/mucous membrane and respiratory tract infections with respiratory 
tract infections necessitating hospital admission in 40.7% of cases.49 Most interestingly of the 
547 HIV-exposed uninfected infants who were followed up for a period of 6 months, 18,8% 
experienced ALRTI (most commonly bronchiolitis).50  Approximately half of these infants 
required hospital admission.  They concluded that infants less than 6 months of age who were 
HIV exposed and whose mothers had a declining CD4 count, were at increased risk of ALRTI 
and severe disease. 
 
Therefore, the HIV-exposed uninfected infant appears to be at increased risk of infectious 
diseases with higher associated morbidity and mortality.   A study in the surgical wards at 
RCWMCH has shown HIV-exposed uninfected infants to be at higher risks of infections, longer 
hospital stays and more complications than their HIV unexposed counterparts during treatment 
for surgical conditions.51  In Johannesburg, the main indicators of infant morbidity and mortality 
are noted to be paediatric HIV infection and maternal viraemia.52 A higher rate of co infections 
with TB, herpes zoster, CMV and syphilis was seen in HIV exposed infants regardless of their 
HIV status/seroconversion status.53  Case reports out of Tygerberg Hospital in Cape Town 
highlight the risks and vulnerability of this unique patient group with an increased infectious 
morbidity rate which may be attributable to a combination of factors.54 
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In the past decade, several interventions have been introduced in South Africa with potential 
impact on HIV-associated LRTI in children including:   
 
1.   Adoption of the Integrated Management of Childhood illness (IMCI) with adaptation to 
include management of HIV-infected children, aimed to target the predominant causes of 
childhood mortality.55 The introduction of the IMCI strategy in many primary health care clinics in 
the Western Cape towards the end of the twentieth century has shown a dramatic improvement 
in the detection of severe disease in children as well as the early and appropriate management 
of common childhood illnesses.56 
 
2. The South African Expanded Program of Immunization (EPI) has seen the addition of new 
vaccines with impact on pneumonia, namely Haemophilus Influenzae type B vaccine in 1999 
and the 13 valent Conjugated Pneumococcal vaccine in 2012.57,58 
  
3.  In 2010, South Africa adopted the World Health Organisation Prevention of Mother to Child 
(PMTCT) guidelines. Current PMTCT coverage is reported as 91.8% either in the form of full 
HAART or antiretroviral prophylaxis to both mother and infant by the Department of Health.  The 
transmission rate of HIV from mother to child in South Africa has subsequently dropped 
significantly and is currently recorded at 3.5%(1.4%-5.9%).47 
 
4.  Early initiation of highly active antiretroviral (HAART) 
It is only in recent years that South Africa has introduced HAART as part of primary care. 
According to current national guidelines, children who are HIV positive are prioritised to initiate 
HAART.59  With the marked recovery of immunological function, there is a decreased trend in 




5.  Chemoprophylaxis.   
Pneumocystis jirovecii has been recognised as an important respiratory pathogen in the 
developed world but has only recently been recognised as important opportunistic infection in 
the South African setting.  Co-trimoxazole prophylaxis should therefore be made available to all 
HIV-infected children as per national SA guidelines.61 
Isoniazid prophylaxis forms part of the national Tuberculosis guidelines. INH prophylaxis is 
indicated for children who are exposed to a household contact with TB or for HIV-infected 
children older than 1 year irrespective of exposure.62,63 
Despite the simplicity and cost effectiveness of co-trimoxazole and isoniazid prophylaxis, these 
strategies for preventing pneumonia remain underutilised.64 
 
6.  Aggressive broad spectrum antibiotic treatment. 
 Recent work in RCWMCH have demonstrated a 21% and 28% prevalence of Pneumocystis 
jirovecii and Cytomegalovirus pneumonia respectively in HIV infected children with severe 
pneumonia.61,65 This knowledge has encouraged the use of broad spectrum empiric antibiotic 
and antiviral cover incorporating high dose Trimethoprim-sulphamethoxazole and Ganciclovir.   
 
7.  Improved access for HIV positive patients to ICU. 
In the setting of limited resources and restricted access to health care, HIV infection places an 
increased demand on intensive care services in the developing world and in South Africa 
particularly. Previous research in this area showed that HIV children admitted to PICU had 
worse outcomes than their HIV negative counterparts.66,67  Admitting HIV positive patients into 
the PICU therefore raised many ethical issues especially around the principle of utilitarianism. A 
study done in the PICU at RCWMCH in 2003-2004 showed an improvement in short and 
medium term outcomes in severely ill HIV infected patients admitted to the PICU with access to 
HAART.  The PICU and hospital mortality rate in this study is shown to be a 25% and 49% 
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respectively.  Those children established on HAART remained well after a median follow up of 
350 days.68  This study highlighted the need for further research into more aggressive 
management of HIV infected children with earlier initiation of HAART.  With earlier access to 
HAART and more aggressive management of pneumonia, this group of children are gaining 




The overall mortality of severe pneumonia and ALRTI of children admitted to intensive care 
units or hospital in LMIC remains high in comparison to WHO standards.  The scarcity of 
resources and the limited availability of intensive care units in LMIC make it even more 
important to understand the factors that place children at risk of severe disease.  A better 
understanding of these factors may assist in mobilising primary health care strategies targeted 
specifically at health promotion and disease prevention in order to improve case fatality and 
overall childhood mortality.  
 
From the review of current literature, we can conclude that there are certain factors that 
distinctly place children at higher risk for acquiring ALRTI and predispose to increased disease 
severity and worsened outcomes.  Modifiable factors that increase the risk of severe ALRTI and 
poorer outcomes include malnutrition, low birth weight and prematurity, poor socioeconomic 
status with overcrowding and poverty, exposure to indoor air pollution related to unprocessed 
solid fuel use and tobacco smoke, comorbid disease and HIV infection.   Of note there is a 
growing awareness and understanding that HIV exposure is as much of a risk as HIV infection 
and disease placing HIV exposed and negative infants at increased risk of severe disease and 




Certain factors such as age and seasonal variation are difficult to modify but perhaps with the 
knowledge that younger children are at risk at certain times of the year it may be prudent to 
increase our surveillance of this age group and develop strategies to offer seasonal 
immunisations to at risk groups of children. 
 
Although a lot of the above mentioned risk factors reflect an overall need to address greater 
health issues and span multiple sectors, there are definitely factors that can be addressed at 
relatively low cost.  It is important to highlight that exclusive breastfeeding for a period of 6 
months is the only protective factor in reducing the incidence and improving the outcomes of 
those admitted with ALRTI revealed in this review.  Breastfeeding needs to be encouraged and 
promoted at all levels of health care to have a greater protective impact on the outcomes of 
severe ALRTI. 
 
If we can reduce the incidence of ALRTI and the severity of disease on presentation, we will be 
able to avoid admission to the PICU and the added morbidity and mortality risks.   
Unfortunately, despite global advances in the management of HIV and pneumonia and despite 
renewed international commitment to decreasing childhood mortality as evidenced by the 
Millennium Development Goals of 2015, ALRTI remain a significant cause of childhood 
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PART B: STUDY PROTOCOL 
Definitions 
“patient” is defined as any child less than the age of 12 years of age presenting to RCWMCH 
in need of medical care. 
“acute lower respiratory tract infection” includes clinical diagnoses in keeping with 
pneumonia; bronchopneumonia; bronchitis; bronchiolitis; or respiratory infection.  It is defined 
according to World Health Organisation as an infection that affects the lungs resulting in the 
symptoms of cough, difficulty breathing and tachypnoea.  
“outcomes” will be defined as: PICU mortality; hospital mortality; duration of invasive 
ventilatory support in days; length of ICU stay in days; length of hospital stay in days. 
“length of stay” for the purpose of this study a day is defined as a 24hour period.  Day one is 
considered to be the first 24 hours or any part thereof.  Thereafter each day will be calculated as 
multiples of 24. 
“ventilatory support” will be considered to be non-invasive (nasal cannula, high flow nasal 
cannula oxygen or non-invasive CPAP) or invasive (positive pressure ventilation or high 
frequency oscillatory ventilation.) 
“cardiac support” will be considered the use of or the administration of inotropic agents. 
“community acquired” is defined as a positive culture from a sample taken within 48hrs of 
hospital admission. 
“nosocomial” is defined as a suspected new sepsis or culture positive sample obtained 48hrs 
after hospital admission. 
“nutritional status” is determined by the WHO classification of malnutrition using Z score cut-
offs of <-2 and <-3 for moderate and severe malnutrition respectively.  In this study, we will look 
at markers for wasting, stunting and underweight.  We will rely on clinical and dietetics 
assessment on nutritional status for final classification. 
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“WAZ” the weight for age Z-score of between -2 and -3 indicates a patient who is moderately 
underweight.  A weight for age Z-score <-3 indicates a patient who is severely underweight. 
“sociodemographic status” is determined on the basis of geographical localisation, income 
bracket and home language. 
“income bracket” is determined by the monthly household income.  It is classified according to 
the provincial government hospital biling department.  
 
Study Aim 
The aim of this study is to describe the clinical features and outcome of patients admitted to a 
Paediatric Intensive Care Unit (PICU) in a tertiary hospital in Cape Town with severe ALRTI and 
to identify risk factors associated with outcome.  The study will include investigation of HIV 
infection or exposure as a risk factor for poor outcome.  
Study Objectives 
Primary Objective 
1 To describe the clinical characteristics, course and outcome of patients admitted to a 
PICU with severe lower respiratory tract disease.   
2 To identify factors associated with worse outcomes. 
Secondary objectives 
1 To establish the impact of specific risk factors on outcomes including:   
● HIV infection or exposure 




● Season of admission 
● Prematurity or history of Low birth weight 
● Comorbidities (Congenital cardiac lesions, genetic syndromes and non-HIV 
immunosuppression) 
● Immunisation status 
● Breastfeeding 
● Recent admission to hospital 
● Socioeconomic status 
● Exposure to indoor air pollution 
 
2 To describe the aetiology of severe ALRTI in children admitted to a PICU. 
3 To identify key areas for further research and make recommendations. 
Methodology 
Study Design 
This is a retrospective descriptive study of the medical records of patients who were admitted to 
the PICU of the Red Cross War Memorial Children’s Hospital from 1st January 2012 - 31st 
December 2012 inclusive with a diagnosis of a ALRTI.  
The estimated sample size is 350 over the study period. 
Study setting 
This study will take place at the RCWMCH in Cape Town, South Africa.  This is a tertiary, 
referral hospital with 300 beds which offers comprehensive specialist and sub-specialist care to 
the paediatric population in the Western Cape.  The study will investigate admission to the 
Paediatric Intensive Care Unit, a 20 bedded multidisciplinary unit with an annual of 7300 PICU 
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bed nights.  The unit had 1259 admission during 2012 with an average length of stay for 
medical admissions of 4 days.  The PICU mortality rate for 2012 was 6.5%. (Personal 
communication Prof Andrew Argent) 
Study population 
Children admitted with a confirmed diagnosis of ALRTI from 1st January 2012 - 31 December 
2012 will be included in the study.   
The PICU database will be screened for any patients with a primary or secondary diagnosis of 
ALRTI.  Each folder will be assessed and data extracted from the patients meeting inclusion 
criteria. 
Inclusion criteria 
1.  Children will be included in the study if they were admitted to the PICU with a diagnosis 
of “pneumonia” or “lower respiratory tract infection” or “bronchopneumonia” or “bronchiolitis” 
or “pulmonary tuberculosis” during the time period from the 1st January 2012 - 31st 
December 2012.  
2.  Age between 0-12years 
 
Exclusion criteria 
1.  A patient who developed a nosocomial ALRTI while admitted in the PICU. 
2. Medical records of patient not obtainable from the RCWMCH records department. 
Research procedures and data collection 
 
The PICU database (Ethics approval number 139/2011) will be used as the primary source of 
information.   The PICU database will be searched for patients using the search terms 
31 
 
“pneumonia” or “lower respiratory tract infection” or “bronchopneumonia” or “pulmonary 
tuberculosis” or “bronchiolitis” in either the “primary diagnosis” or “secondary diagnosis” 
category.  Any child who is admitted to the PICU with these diagnoses from the 1st January 
2012 - 31st December 2012 will be screened for enrolment on the study.  A list of patients 
meeting the study criteria will be generated.   The folders of the list of patients will be requested 
from medical records to verify information.  The baseline patient characteristics and admission 
details will be obtained from the PICU database.  Information regarding the aetiology, clinical 
severity and outcome of the pneumonia will be obtained from the medical folders.  If a full set of 
data is not obtainable from the medical records, results of investigations performed while in the 
PICU will be sought from the National Health Laboratory Service (NHLS).  Chest radiographs 
performed on admission to the PICU will be reviewed on the electronic Paxim system.  The X-
rays will be reread and analysed by two readers with a third reader for discrepant results using 
the WHO standardised definitions of interpretation of chest radiographs for the diagnosis of 
pneumonia. 
 
Patient information from the PICU database, the medical records and NHLS will be carefully 
reviewed in a confidential manner by the primary investigator.  Relevant data will be extracted 
from the medical records.   
 
The data will be collected by the primary investigator and abstracted to an electronic data 
capture sheet (See Appendix C).  Once collected, the data will be entered into an Epidata 
spread sheet.  Restricted access by means of an account username and password for the 
database held by the primary investigator will ensure patient privacy at all times.  Identification 
of patients will be by means of a unique ICU admission number to further ensure patient 




The data once captured on an Epidata Database will be analysed descriptively using 
appropriate statistical methods using the Stata program.  Continuous variables will be assessed 
for normality by drawing histograms and formally tested using the Shapiro-Wilks test and the 
appropriate parametric and nonparametric statistics applied.  Proportions will be described with 
a 95% confidence interval.  Associations between categorical variables will be assessed using 
the Chi-Square test or Fisher’s exact test if the expected frequency in any cell is less than five.  
Logistical regression analysis will be performed on risk factors identified by the current literature 
review and defined by the list of risk factors in the objective above.  Any factor in the univariate 
analysis which show a trend towards statistical importance with a p<0.26 as well as any other 
factor chosen by virtue of clinical reasoning will be included in the multivariate logistic 
regression analysis.   
The assistance of a statistician will be sought to ensure accurate results. 
Time frame 
Following ethics and departmental approval, the study will commence and will run over a 6-
month period allowing for complete data capturing and analysis. 
Description of risks and benefits 
Risks: 
There are no risks to the patients or attending clinicians. 





The potential benefits of the study are a better awareness and understanding of the outcomes 
of patients admitted to the PICU with ALRTI and therefore the opportunity to explore strategies 
for improved patient care. 
 
Dissemination of Data 
A written report of all data and findings will be made available to the Departmental Research 
Committee and the clinical staff of the PICU at RCWMCH.  Findings will be presented to the 
clinical staff of RCWMCH at paediatric academic meetings and at national congresses. 
I will endeavour to publish the results in a major international journal. 
An abstract will be submitted for conferences. 
Ethical considerations 
This is a low risk study. 
 
Approval for the study will be obtained by the Departmental Research Committee, School of 
Child and Adolescent Health as well as the Human Research Ethics Committee of the Faculty of 
Health Sciences, University of Cape Town. 
As the study is a retrospective review of medical records informed consent will not be obtained.  
No interventions are planned and no risks are foreseen. 
 
Patient confidentiality will be maintained at all times by means of a unique ICU admission 
number use as identification and all data being kept in a restricted access setting.  All patient 
identifying data including date of birth and physical address have been excluded from the study. 
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Objective: Acute lower respiratory tract infection (ALRTI) remains an important cause of 
childhood morbidity and mortality in low and middle income countries (LMIC). This study aims to 
describe the clinical features of children admitted to a Pediatric Intensive Care Unit (PICU) with 
severe ALRTI and to investigate risk factors, clinical course and in-hospital outcome.    
Design: Retrospective cohort study  
Setting: Red Cross War Memorial Children’s Hospital, Cape Town, South Africa 
Patients: 265 children (0-12years) admitted to the PICU during 2012 with a primary diagnosis 
of ALRTI. 
Intervention: None. 
Measurements and main results: 265 patients [median (interquartile range, IQR) age 4 
months (2-12months)] were admitted with ALRTI, 157(59.3%) were male. Co-morbid disease 
was present in 102(38.5%) including cardiac disease in 42(15.9%) or tuberculosis in 7(6.4%) . 
While only 27(10.2%) were HIV infected, 87(32.8%) children were HIV exposed.   
The in-hospital mortality was 34(12.8%); 24(9.1%) died in PICU and a further 10 in the medical 
wards following discharge from PICU.  The median duration of ICU and hospital stay was 4.0 
days (2.0-8.0) and 12.5 days (7.9-28.0) respectively. Most [192 (72.5%)] children required 
invasive ventilatory support, while 42 (15.8%) patients required cardiac inotropic support. 
Risk factors for mortality included severe malnutrition (Odds ratio (OR) 8.25; 95% CI 1.47-
46.21); informal housing without access to piped water and/or electricity (OR11.87; CI 1.89-
20.81); or need for inotropic support (OR 44.35; CI 8.20-239.92). HIV exposure or infection was 
associated with a significantly longer duration of hospital stay (p=0.002). 
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Conclusion: Severe ALRTI occurs predominantly in young infants and is associated with a high 




























Acute lower respiratory tract infection (ALRTI), primarily pneumonia is a leading cause of death 
in children under the age of five years, placing a considerable burden on health and economic 
resources particularly in low and middle income countries (LMICs)(1).  The World Health 
Organisation (WHO) recognises that pneumonia alone is responsible for up to 15% of deaths in 
children under the age of five years(2).  In Sub Saharan Africa, pneumonia is the most important 
cause of under 5-year mortality outside the neonatal period(3).  In South Africa and the Western 
Cape, pneumonia accounts for 9.1-15.2% and 23% of all under 5 year deaths respectively(4,5).  
Data from the Medical Research Council Burden of disease report 2015 found that pneumonia 
remains one of the leading causes of death in hospital in South African children under 5 
years(4).  
In South Africa there is very little data on outcome of severe ALRTI.   WHO estimated 
19.2 million cases of severe ALRTI in 2010 with the majority of those (62%) being treated in a 
hospital setting(6). The in-hospital case fatality rate estimated by WHO is between 2.3 and 6% 
depending on severity of disease(6).  A study done in 1998 at Red Cross War Memorial 
Children’s Hospital (RCWMCH) of HIV infected and uninfected children admitted to PICU with 
ALRTI reported a mortality rate of 29% and 14% respectively(7).  Importantly this study 
preceded the roll out of highly active antiretroviral therapy (ART) for children, thus giving an 
explanation for the marked discrepancy in survival.   The limited South African data suggests a 
much higher case fatality rate than that reported by the WHO(6) and highlights the need for 
further research into the causes, risk factors and outcome of severe ALRTI in this setting. 
Several factors may predispose children to ALRTI and to severe disease.  Reported risk 
factors include age less than 1 year(8,9) in South Africa, children less than 10 weeks of age are 
at greatest risk for respiratory tract infection(10); prematurity (gestational age < 36 weeks) or 
low birth weight of <2.5kg(11,12,13); severe or moderate malnutrition according to WHO 
39 
 
classification(14), micronutrient deficiency or comorbid disease (especially congenital cardiac 
disease(15) and immunosuppressive disease especially HIV infection(16)). Increasing evidence 
suggests that HIV-exposed uninfected children have a higher risk for ALRTI or opportunistic 
infections than unexposed children(17,18).  A protective factor that was identified in many 
studies is exclusive breastfeeding for 6 months(19,20,21); protection wanes with age but 
exclusive breastfeeding may halve the risk of ALRTI in infancy. 
 
This study aims to describe the clinical characteristics and outcomes of children with severe 
ALRTI admitted to a Paediatric Intensive Care Unit (PICU) in a tertiary hospital in South Africa 
and to identify risk factors associated with in-hospital mortality.   
Methods 
Study Design and setting 
This was a retrospective, descriptive cohort study of patients admitted to the PICU at Red Cross 
War Memorial Children’s Hospital (RCWMCH) with a diagnosis of ALRTI.  
RCWMCH in Cape Town is a tertiary, referral hospital with 300 beds, which offers 
comprehensive specialist and sub-specialist care to the paediatric population in the Western 
Cape.  The PICU is a 20-bedded multidisciplinary unit with 7300 annual bed nights available.  
Study Population 
Children up to 12 years who were admitted with a confirmed diagnosis of ALRTI from January 
2012 - December 2012 inclusive were included in the study. 
Children who developed an ALRTI while already admitted in the PICU or those for which the 





The PICU database (Ethics approval 139/2011) was used to identify patients with a primary or 
secondary diagnosis of lower respiratory tract disease using medical subheadings “pneumonia” 
or “lower respiratory tract infection” or “bronchopneumonia” or “bronchiolitis” or “pulmonary 
tuberculosis”. 
Details of the PICU stay were obtained from the database.  The medical records and 
National Health Laboratory service records were used to gain further clinical information 
regarding risk factors and results of investigations performed during the admission.  
All data were collected on electronic data capture forms and held by the primary investigator 
using password protected computer software namely EpiData Entry version 2.0 (The EpiData 
Association, Denmark, Europe) and Tap Forms organiser version 4.0.5 (Tap Zapp Software Inc, 
Calgary, Canada).  A database was generated in Microsoft Excel from the collective data 
preserving patient confidentiality by means of a unique ICU admission number. 
 
Study variables 
   For the purpose of this study, the following terms needed to be defined: 
 “Acute lower respiratory tract infection” includes clinical diagnoses in keeping with 
pneumonia; bronchopneumonia; bronchitis; bronchiolitis; or respiratory infection.  It is defined 
according to World Health Organisation as an infection that affects the lungs resulting in the 
symptoms of cough, difficulty breathing and tachypnea.  
“Outcomes” will be defined as PICU mortality and in-hospital mortality. 
“Length of stay” for the purpose of this study a day is defined as a 24hour period.  Day one is 
considered to be the first 24 hours or any part thereof.  Thereafter each day will be calculated as 
multiples of 24. 
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“Ventilatory support” will be considered to be non-invasive (nasal cannula, high flow nasal 
cannula oxygen or non-invasive CPAP) or invasive (positive pressure ventilation or high 
frequency oscillatory ventilation.) 
“Cardiac support” will be considered the use of or the administration of inotropic agents. 
“Nosocomial” is defined as a suspected new sepsis or culture positive sample obtained 48hrs 
after hospital admission. 
“Nutritional status” is determined by the WHO classification of malnutrition using Z score cut-
offs of <-2 and <-3 for moderate and severe malnutrition respectively (looking at markers for 
wasting, stunting and underweight.)  The specialist PICU dietician’s clinical assessment was 
used as the final classification. 
“Prematurity” was defined as birth prior to 37 completed weeks of gestation.  
“Birthweight” was categorised as low birthweight <2.5kg; very low birth weight 1.00-1.49kg 
and extremely low birthweight <1.0kgs. Fenton’s correction scale was used to adjust for 
gestational age in ex premature patients when assessing birthweight and current weight in 
terms of z-scores(23).   
“Socioeconomic status” is determined on the basis of type of housing with/without access to 
piped water and electricity and income bracket classified according to the provincial government 
hospital billing department. 
 “Feeding choice” Choices recorded were based on maternal self-report (exclusive breast, 
exclusive formula or mixed feeding) up to and including admission to hospital; mixed feeding 
was considered any child who had a mixture of breast and formula milk or any other oral 
substance used for nutrition purposes prior to admission.   
“HIV status” was confirmed using results accessed via the National Health Laboratory Services 
(NHLS).   
“HIV exposure” was recorded from the notes and not verified via the NHLS due to ethical 
concerns obtaining parent’s health information retrospectively.   
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“Prevention of mother to child transmission (PMTCT)” data was defined according to 
current applicable Department of Health guidelines, which have subsequently been updated.  
For the purpose of this study, antenatal PMTCT included mothers who received antiretroviral 
therapy (either Zidovudine or combination drug therapy) prior to the start of labour; perinatal 
PMTCT included Zidovudine and Nevirapine therapy given to the mother during labour as well 
as a dose of Nevirapine administered to the infant; Post-natal PMTCT included 6 weeks of 
Nevirapine to the infant (or longer if breastfeeding.) 
“Paediatric index of mortality score (PIM2)” this score is a composite of clinical factors, 
biochemical markers, ventilatory requirements as well as underlying risk factors at the time of 




The data was analysed using STATA 13 statistical software (STATA Corporation, 
College Station, TX, USA).  
Exploratory data analysis of categorical and continuous variables included frequency    
tables and histograms to determine distribution.  Simple descriptive statistics were used to 
characterise the study population.  Normally distributed continuous data were summarised by 
mean and standard deviations (SD); non-normally distributed continuous data by median and 
interquartile range (IQR).  Categorical data were summarised as number and proportion.  
Statistical tests included Chi-square test (adjusted if number less than 5) and Kruskal-Wallis 
comparison of medians and Student’s t-test for comparison of means.  Risk factors that tended 
towards statistical significance (p<0.26) or those specifically chosen based on clinical reasoning 
were included in a multivariate cox regression analysis, which included both forward and 
backward regression.  Factors considered to be competing risk factors for mortality were 
excluded namely duration of PICU stay and invasive ventilatory requirements. HIV infection and 
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breastfeeding were treated as potential confounding variables.  Statistical tests were two sided 
at α = 0.05.  
 
Ethical considerations 
Ethical approval for the research was granted by the University of Cape Town Faculty of Health 








358 patients identified 
on the PICU database 
85 patients excluded 
as they developed 
ALRTI in the ICU 
8 missing folders 
265 patients included 








Table 1. Baseline characteristics of children admitted with a diagnosis of ALRTI, 
by hospital outcome (survived/died) 
Characteristic All N (%) Survived N (%) Died N (%) OR1 (95% CI2) P value 
Gender  
N (%) male 
157 (59.3%) 133 (57.6%) 24 (70.6%) 1.76 (0.80-3.86) 0.153 
Age in months 
Median (IQR) 
4 (2 – 12) 4 (2 – 12) 6.5 (2.5 – 12) 1.00 (0.98-1.01) 1.00 
Age category 
< 10 weeks 


















-0.8 (-1.4; 0) -0.8 (-1.4; 0.1) -0.9 (-1.5-0.5) 0.88 (0.63; 1.23) 0.458 
Preterm (< 37 weeks) 60 (22.6%) 53 (22.9%) 7 (20.6%) 0.87 (0.36-2.11) 0.759 
HIV status N (%) 






















PMTCT4  N (%) 
Antenatal received 
Perinatal received 
Postnatal - correct  


























Infant feeding N (%) 
























   None/mild 
   Moderate 





















                                                 
1 Odds ratio 
2 Confidence interval 
3 Adjusted for gestation using Fenton’s calculation 




< R4000 per month 
































Tobacco Smoke exposure  
(self-report) 
59 (25.1%) 56 (26.8%) 3 (11.5%) 0.36 (0.10-1.23) 0.103 
TB disease5 17 (6.4%) 14 (6.1%) 3 (8.8%) 1.50 (0.41-5.52) 0.542 
Hospital acquired 
infection (suspected) 
72 (27.2%) 60 (25.9%) 12 (35.3%) 1.56 (0.73-3.33) 0.257 






















Inotropic support  42 (15.7%) 18 (7.8%) 23(67.7%) 24.7 (10.4-58.7) <0.001 
Length of time to start 
antibiotics (hours) 
1 (1-3) 2 (1-3) 1 (1-2) 1.29 (0.98-1.70) 0.068 
At least one dose of 
prevenar administered 
180 (67.9%) 155 (67.1%) 25 (73.5%) 1.36 (0.61-3.06) 0.455 
Duration in PICU (days) 4.0 (2.0-8.0) 4 (2.0-7.0) 5.0 (2.0-12) 
1.00 (1.00 – 
1.01) 
0.053 
Duration in hospital (days) 
12.5 (7.9-
28.0) 
12.9 (8.1-27.0) 8.35 (2-48) 
1.01 (1.00 – 
1.02) 
0.008 







                                                 





           Of 265 patients admitted to PICU, 34(12.8%) died in-hospital; 24(9.1%) died in PICU and 
a further 10 in the medical wards following discharge from PICU.  The median duration of 
hospital stay was 12.5 days (7.9-28.0).  The median duration of ICU stay was 4.0 days (2.0-8.0).   
Ventilatory support was required by 250(94.3%) of patients with a mean duration of all forms of 
ventilatory support of 3.5 days (1.5-6.9).  Many children required more than one form of 
respiratory support during their PICU stay as they recovered or deteriorated.  Overall, invasive 
ventilatory support (Conventional mechanical ventilation or High frequency oscillatory 
ventilation) was necessary in 192(72.5%) patients.  Inotropic support for haemodynamic 
instability or cardiac failure was necessary in 42(15.7%) of patients.  
          The 265 patients used a total of 1544 PICU days which is approximately 21% of the 
annual available bed days. The mean PIM2 score was 0.134 (SD 0.192) indicating a risk of 
mortality on admission of 13.4%.  The PIM2 score can be used to calculate the Standardised 
mortality rate (SMR) by dividing the actual mortality by the mean predicted mortality score.  The 
SMR can then be a useful marker of the quality of care or performance in the unit.   In this study 
the calculated SMR in the PICU and overall in-hospital following PICU discharge was 0.70 and 
0.99 respectively. 
          When evaluating for causes of mortality in the PICU the main causes were multi-organ 
failure (16(47.1%)), respiratory failure (4(11.8%)) or those associated with complex congenital 
cardiac disease who died from cardiac failure (3(8.8%)).  Of the deaths that occurred in the 
ward following discharge from the PICU, only 1 out of the 10 was unexpected and related to a 
cardiac arrest caused by electrolyte disturbances.  The other patients were discharged from the 
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PICU for palliation due to either severe hypoxic brain damage or significant lung disease 
occurring during the PICU stay. 
Risk factors for Death  
          On univariate analysis the following factors showed a statistically significant effect on 
outcome:  exclusive formula feeding (OR 0.31 95% CI 0.10-0.96); mixed feeding (OR 0.36 95% 
CI 0.14-0.94); severe malnutrition (OR 4.99 95% CI 2.90-11.90); informal housing (OR 2.87 
95% CI 1.30-6.30); associated cardiac disease (OR 2.89 95% CI 1.20-6.95); bacteria isolated 
from a normally sterile site (OR 4.01 95% CI 1.53-10.54); need for inotropic support (OR 24.7 
95% CI 10.4-58.7) and duration in hospital (OR 1.01 95% CI 1.00-1.02).  These variables as 
well as age, prematurity, HIV status, time to first dose of antibiotics and duration in PICU were 
included in the multivariate analysis as they were considered clinically important factors both in 
the literature and in personal clinical practice.  The multivariate analysis with adjusted odds 
ratios showed significance of the following factors: severe malnutrition; informal housing; 
inotropic support and duration of hospital stay.  These factors were associated with a 
statistically significant higher risk of in hospital mortality, after adjusting for HIV infection, 
prematurity, age at admission and method of feeding (table 2).  Age, birthweight, prematurity, 
feeding choice, HIV status or comorbid disease, time to start antibiotics, seasonal variability, 
nosocomial infection and tobacco smoke exposure were not associated with survival in this 







Table 2. Multivariate analysis of risk factors for children admitted with a diagnosis 
of ALRTI, by hospital outcome (survived/died) 
 Univariate association Multivariate association 
 OR (95% CI) P value OR (95% CI) P value 
Age category 
< 6 months 
0.59 (0.29-1.21) 0.150 0.82 (0.19-3.56 0.794 
HIV status N (%) 
Exposed; not infected 
Exposed; Infected 












Preterm (< 37 weeks) 0.87 (0.36-2.11) 0.759 1.62 (0.31-8.33) 0.565 
Infant feeding N (%) 





4.38 (0.92-20.82) 0.063 
Nutritional status 
  None/mild 
  Moderate 


















  Formal 













Bacterial isolate 4.01 (1.52-10.54) 0.005 3.61 (0.65-20.00) 0.141 















Inotropic support  24.7 (10.4-58.7) <0.001 44.35 (8.20-239-9) <0.001 
Length of time to start 
antibiotics (hours) 
1.29 (0.98-1.70) 0.068 0.71 (0.37-1.35) 0.294 
Duration in hospital 1.01 (1.00 – 1.02) 0.008 1.04 (.01-1.06) 0.007 




Impact of HIV exposure and infection on outcomes. 
          In this study sample, 87 (32.8%) of patients were HIV exposed and 25 (10.2%) were 
confirmed to be HIV infected.  The Mother to Child HIV transmission rate in this study is 31.0%. 
Details of PMTCT as follows reveals low coverage in the HIV exposed group and less than 
would be expected for a successfully PMTCT program:  antenatal coverage 44(50.6%); 
perinatal coverage 50(57.5%) and postnatal coverage 54(62.1%).  Only 6 infants received full 
PMTCT including all three components at the correct dosing, of these patients 3 were breastfed; 
1 was formula fed and 2 received mixed feeding.  9 patients did not receive any PMTCT at all 
prior to admission.  4 patients received incomplete PMTCT.  These infants only received 
postnatal PMTCT.  The assumption is that these mothers were diagnosed in labour or at the 
delivery of the infant.  2 of the patients had all the components of PMTCT but the dosing of 
Nevirapine was incorrect.  In 6 patients who were tested HIV positive on this admission, the 
medical records did not contain any information about PMTCT. 
        Of the HIV infected group, 22 patients were newly diagnosed on the current admission with 
a mean viral load of 2 660 254 (log 6.4); mean CD4 count of 23% and mean WHO clinical stage 
of 3.75. Of the 5 patients known to be HIV infected, 4 were on first line ART, one was on second 
line ART but only two patients were virally suppressed on therapy.  
          HIV exposure or infection did not significantly affect mortality however HIV infection was 
associated with a higher PIM2 score on admission and longer duration of PICU and hospital 





TABLE 3: Impact of HIV exposure/infection on outcomes 
 
Characteristic HIV unexposed HIV exposed, 




Survival rate 0.87 0.87 0.89 0.740 










Duration hospital stay in 
days (median/IQR) 
11.0 (7.2-27.0) 11.0 (7.9-24.4) 23.0 (16.1-43.0) 0.002 
Duration ICU stay in days 
(median/IQR) 
4.0 (2.0-8.0) 4.0 (2.0-7.0) 6.0 (4.0-10.0) 0.131 
PIM2 score (mean) 0.115 0.116 0.315 <0.001 
 
Aetiology 
          Overall 960 investigations in total were done to try identity a potential cause of the ALRTI. 
Tests performed included culture of blood, induced sputum, tracheal aspirate, broncho-alveolar 
lavage and pleural fluid for bacteria and fungi; viral polymerase chain reaction (PCR) panel 
testing for 7 respiratory viruses on nasopharyngeal aspirate and TB microscopy and culture as 
well as PCR on induced sputum and gastric washings.  Of the 265 patients admitted to PICU, 
206(77.7%) patients had at least one organism identified on investigations and 86(32.5%) 
patients had more than one organism identified (table 4).  Viruses were most commonly 
identified 117(44.2%) with a frequency of Respiratory Syncytial virus, Rhinovirus and 
Adenovirus of 9.3%, 7.2% and 4.7% respectively. 
          CMV was tested by means of a quantitative viral load with a log >4 considered to be 
positive for disease.  18 patients out of 27 who were tested had a CMV log > 4 (66.7%).  CMV 
testing was only done in patients known to be HIV-infected.  There was no significant difference 
in aetiology between the HIV unexposed, HIV exposed-negative and HIV infected groups (p-
value=0.2).   
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          Children who had a bacteria isolated from blood culture, broncho-alveolar lavage, sputum 
or histology were three times more likely to die compared to viral, fungal or mixed causes for 
ALRTI (OR 3.61 95% CI 0.65-20.00) (table 2). 
TABLE 4: Organism type isolated from investigations in the PICU 
Organism isolated Number Proportion Odds ratio (95% 
CI) 
P value 
None 59 22.3% - - 
Bacteria1 
1x bacterium isolated 









1x virus isolated 



































1Bacteria were isolated from blood culture, broncho-alveolar lavages, culture of tracheal aspirates or pleural fluid. 




This study provides new data on the risk factors and outcome of South African children 
with severe ALRTI admitted to a PICU and reflects a much larger burden of childhood 
disease(1,6,26).   The severity of illness in this population was extremely high as evidenced by 
the high PIM2 scores and requirement for mechanical ventilation, with almost all children 
receiving ventilatory support, mostly conventional or high frequency oscillatory ventilation.  The 
requirement for mechanical ventilation (72.5%) was much higher than in other LMICs such as 
South America or China where rates of mechanical ventilation in children admitted to PICU with 
severe ALRTI are reported as 55% and 21% respectively(8,27). The PIM2 score on admission 
to PICU predicted a mortality of 13%, but the mortality rate in the PICU was 9%.  This affirms 
the high quality of care received by children admitted to this unit and can be attributed to 
strategies used including broad spectrum antibiotics, lung protection ventilator strategies and 
preventative interventions to decrease the risk of nosocomial infection or other complications all 
of which may be important factors resulting in better than expected outcomes.  The further ten 
patients who died following discharge from the PICU increase the overall mortality to 13%, but 
all of these deaths, except one, were anticipated and palliation had begun within the PICU or 
shortly after discharge.  These outcomes are especially encouraging in comparison to other 
LMICs such as South America or China who report PICU mortality rates from severe ALTRI of 
13% and 5.8% respectively(8,27).     
 Several factors were identified as influencing in-hospital mortality.  Of these, 
socioeconomic factors were a key determinant associated with both admissions to PICU and of 
survival.  Children from impoverished backgrounds living in informal housing without access to 
electricity and running water on their property had almost four times the rate of mortality.  The 
PIM2 score on admission to the PICU was significantly higher for children living in informal 
housing.  Lack of access to basic amenities such as running water, adequate sanitation or 
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electricity were associated with higher mortality as well as with a higher PIM2 score on 
admission.  A recent study in this geographical area reflects that children from informal housing 
are more severely ill at PICU admission, possibly reflecting higher prevalence of risk factors for 
illness as well as poorer access to healthcare, unnecessary delays in diagnosis or referral 
patterns(26).  Our study corroborates these findings and although children from poorer 
socioeconomic backgrounds received the same treatment as those from richer backgrounds, 
the higher mortality of the former may be a result of their greater severity of illness or underlying 
co-morbidity.  
 This study does not seem to show that exclusive breastfeeding for a duration of 6 
months is a protective factor when it comes to severity or survival.  This is in contradiction to the 
current literature and clinical understanding.  A possible explanation for this may be the very 
young age of the study sample population (median age 4 months) with almost half of the deaths 
(15 out of 34) occurring before the age of 6 months.  If the deaths are scrutinised, even though 
there was no statistical significance to verify this fact, 7 of the deaths had complex congenital 
cardiac disease, 3 had HIV disease and 3 had other comorbidities so even though they were 
breastfeeding, as a single protective factor it may not have made enough of a difference.  The 
sizes of the samples and groups of survivors versus deaths may also not be large enough to 
show a true protective effect. 
HIV infection has long been recognised as a risk factor for more severe disease and 
worse outcome from ALRTI.  The mortality rate of HIV infected children in the current study was 
11%, substantially lower than that predicted by the PIM2 score (mean PIM2 score of 31.5%).  
Further, this was much lower than previously reported in a study done at RCWMCH in 1998 
which reported a mortality rate in HIV infected and uninfected children admitted to PICU with 
pneumonia of 29% and 14% respectively(28).  However, other intensive units in South Africa 
continue to report mortality rates for HIV infected children of approximately 30%(29).  The 
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success of early detection of HIV infection with timely initiation of HAART as well as aggressive 
broad spectrum management of ALRTI with HIV infected children in a PICU setting may explain 
these impressive reductions in mortality.  Such outcomes support the decision to accept HIV 
infected children into the PICU for supportive treatment which in the era before ART was 
perhaps not justified(30,31).  However, the duration of PICU and hospital stay of HIV infected 
children were almost double that of HIV uninfected children, confirming that this is a vulnerable 
population who are still at substantial risk for severe disease and who still constitute a large 
burden on the health system. 
Recently, HIV exposure has also been associated with a higher risk of pneumonia, as 
shown by a South African study in which HIV negative children born to HIV-infected mothers 
had a higher rate of pneumonia in the first year of life compared to those born to HIV-negative 
women(32).  Just over 30 % of this study population were HIV exposed which is in keeping with 
antenatal HIV positive rates in 2012 of approximately 29% in this geographical area.  However, 
the documented transmission rate in the Western Cape in the setting of fully implemented and 
effective PMTCT is 1.4%(33).   Of the 25 children who were HIV infected, 17 either had no 
documented PMTCT, incomplete PMTCT or incorrect PMTCT dosages, highlighting that 
implementation of effective PMTCT programs may still be problematic.  As PMTCT programs 
are strengthened, so increasing attention must be given to HIV exposed but uninfected children 
who represent an emerging, important vulnerable group.  
 
Study limitations 
This study has several limitations. As the study was retrospective, there was limited 
ability to have complete, detailed data records and standardised measures of certain tests and 
investigations. Nevertheless, the abstracted clinical data was consistent for all children and 
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comprehensive, given the strong PICU data base. Factors that relied on medical records and 
documentation had a completeness of approximately 76-96% which was deemed suitable for 
data analysis. 
In terms of outcomes, it has to be acknowledged that certain factors can be seen to be 
competing risk factors for outcome e.g. duration of ventilation was used as a risk factor for 
outcome but could also be referred to as an outcome in and of itself.  This complex relationship 
between risk factors and outcomes makes the interpretation difficult.  It was therefore decided to 
focus on survival as the only outcome of this study.  All other outcomes including length of 
hospital stay, length of PICU stay and duration of ventilation are important and warrant further in 
depth analysis in future publications. 
Further, the ability to attribute aetiology was limited as aetiological investigations were 
highly variable and attributing aetiology in childhood ALRTI may be especially difficult.   The 
sample of patients in the PICU represent the sickest children, therefore these results may not be 
generalizable to children with lesser severity of illness.  Further, the sample size was relatively 
small, but representative of a full year of PICU admissions for LRTI, thus accounting for 
seasonal variation.   
In conclusion, children admitted for ALRTI to the PICU at RCWMCH in 2012 had severe 
disease on admission but despite this had fairly good outcomes in terms of survival, better than 
predicted and much improved from a decade earlier.   Several risk factors for poor outcome 
were shown, which require broad interventions to effectively address these.   Future research 
should investigate the morbidity related to severe ALRTI and the long term outcomes such as 
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Appendix A: Definitions  
 
Classification of the severity of pneumonia by World Health Organisation 
Sign or symptom Classification 
1 Fast breathing 
2 Definite crackles on 
            auscultation 
 
Pneumonia 
As above plus: 
1 Chest in drawing 
Severe pneumonia 
 
As above plus: 
1 Central cyanosis  
2 Severe respiratory distress (e.g. head 
nodding)  
3 Not able to drink 
 
Very severe pneumonia 
 
Reference ranges for fast breathing: 
≥60 breaths/minute in a child aged <2 months 
≥50 breaths/ minute in a child aged 2–11 months  




“patient” is defined as any child less than the age of 12 years of age presenting to RCWMCH in 
need of medical care. 
“acute lower respiratory tract infection” includes clinical diagnoses in keeping with 
pneumonia; bronchopneumonia; bronchitis; bronchiolitis; or respiratory infection.  It is defined 
according to World Health Organisation as an infection that affects the lungs resulting in the 
symptoms of cough, difficulty breathing and tachypnoea.  
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“outcomes” will be defined as: PICU mortality; hospital mortality; duration of invasive 
ventilatory support in days; length of ICU stay in days; length of hospital stay in days. 
“length of stay” for the purpose of this study a day is defined as a 24hour period.  Day one is 
considered to be the first 24 hours or any part thereof.  Thereafter each day will be calculated as 
multiples of 24. 
“ventilatory support” will be considered to be non-invasive (nasal cannula, high flow nasal 
cannula oxygen or non-invasive CPAP) or invasive (positive pressure ventilation or high 
frequency oscillatory ventilation.) 
“cardiac support” will be considered the use of or the administration of inotropic agents. 
“community acquired” is defined as a positive culture from a sample taken within 48hrs of 
hospital admission. 
“nosocomial” is defined as a suspected new sepsis or culture positive sample obtained 48hrs 
after hospital admission. 
“Nutritional status” is determined by the WHO classification of malnutrition using Z score cut-
offs of <-2 and <-3 for moderate and severe malnutrition respectively.  In this study, we will look 
at markers for wasting, stunting and underweight.   
“WAZ” the weight for age Z-score of between -2 and -3 indicates a patient who is moderately 
underweight.  A weight for age Z-score <-3 indicates a patient who is severely underweight. 
“Sociodemographic status” is determined on the basis of geographical localisation, income 
bracket and home language. 
“Income bracket” is determined by the monthly household income.  It is classified according to 






Appendix B: Standardised interpretation of paediatric chest radiographs 
 
 FINDING DEFINITION 
Film quality Uninterpretable Features of the image are not interpretable with respect to presence 
or absence of “primary end-point” without additional images 
 Suboptimal  Features allow interpretation of primary end-point, but not of other 
infiltrates or findings; no entries were made for “other infiltrates” for 
such images 




Significant pathology Refers specifically to the presence of consolidation, infiltrates or 
effusion 
of findings 
 End-point consolidation A dense or fluffy opacity that occupies a portion or whole of a lobe or 
of the entire lung, that may or may not contain air-bronchograms 
 Other (non-end-point) 
infiltrate 
Linear and patchy densities (interstitial infiltrate) in a lacy pattern 
involving both lungs, featuring peribronchial thickening and multiple 
areas of atelectasis; it also includes minor patchy infiltrates that are 
not of sufficient magnitude to constitute primary end-point 
consolidation, and small areas of atelectasis which in children may be 
difficult to distinguish from consolidation 
 Pleural effusion Presence of fluid in the lateral pleural space between the lung and 
chest wall; in most cases, this will be seen at the costo-phrenic angle 
or as a layer of fluid adjacent to the lateral chest wall; this does not 
include fluid seen in the horizontal or oblique fissures 
Conclusion Primary end-point 
pneumonia  
The presence of end-point consolidation (as defined above) or pleural 
effusion that is in the lateral pleural space (and not just in the minor or 
oblique fissure) and was spatially associated with a pulmonary 
parenchymal infiltrate (including other infiltrate) OR if the effusion 
obliterated enough of the hemithorax to obscure an opacity 
 Other infiltrate The presence of other (non-end-point) infiltrate as defined above in 
the absence of a pleural effusion 
 No consolidation/infiltrate/ 
effusion 








Appendix C:  Data Capture form 
 
 
ICU Admission number 
Patient details:  
Hospital number  
Age in months _ _ _ months 
Sex  Male                        
 Female  




Geographical area of residence  









Hospital details  
Date of admission to RCWMCH _ _/_ _/2012 
Date of admission to PICU _ _/_ _/2012 
Date of discharge from PICU _ _/_ _/2012 
Date of discharge from RCWMCH _ _/_ _/2012 
Duration of PICU stay(hours)  
Duration of hospital stay 
(hours) 
 




Morbidity or mortality in RCWMCH  Survived 
 Died 
  
Details of PICU stay:  
Primary diagnosis  Lower respiratory tract infection 
 Pneumonia 
 Bronchopneumonia 
 Pulmonary Tuberculosis 
 Bronchiolitis 
Secondary diagnosis  
PIMMS score on admission  
Need for ventilatory support  No 
 Yes 
Need for High flow nasal cannula oxygen  No 
 Yes 
Need for non-invasive CPAP  No 
 Yes 








Duration of ventilatory support (hours)  
Need for inotropic support  No 
 Yes 
Duration of inotropic support (hours)  
  
Risk factors:  
Weight of the child _ , _ _kg 
Length of the child _ _ _ cm 
Nutritional status  Normal 
 Mildly malnourished 
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 Moderately malnourished 
 Severely malnourished 
 Unknown 





Gestational age at birth _ _ weeks 
Birth weight _ , _ _ kg 
Any respiratory complications at birth  No 
 Yes 
Immunisation status  Birth immunisations        Date: _ _/_ _/_ _ _ _ 
 6 week                            Date: _ _/_ _/_ _ _ _ 
 10 week                          Date: _ _/_ _/_ _ _ _ 
 14 week                          Date: _ _/_ _/_ _ _ _ 
 9 months                         Date: _ _/_ _/_ _ _ _ 
 18 months                       Date: _ _/_ _/_ _ _ _ 
 6 years                            Date: _ _/_ _/_ _ _ _ 
 
 Unknown                            




Mother’s age _ _ years 
Number of siblings  
Type of housing  Formal 
 Informal 
Exposure to TB within last 6 months  No 
 Yes 
Is child currently on INH prophylaxis  No 
 Yes 
Ever diagnosed with TB  No 
 Yes Previously 
 Yes Currently 
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Ever treated for TB  No 
 Past 
 Current – New treatment 
 Current – Retreatment 
 Defaulted 
Clinical suspicion of TB  No 
 Yes 
Congenital cardiac disease  No 
 Yes 
Other comorbid condition present  No 
 Yes            Specify:___________________________ 









HIV status:  
Is the child HIV exposed?  No 
 Yes 
Mom received ARVs in pregnancy?  No 
 Yes 
 Not recorded 
 Not applicable 
Perinatal PMTCT  No 
 Yes 
 Not recorded 
 Not applicable 
Did infant receive Nevirapine  No 
 Yes – Dose correct 
 Yes – Dose incorrect 
 Not recorded 
 Not applicable 







Is the child HIV infected  No 
 Yes 
 Still to be confirmed 
 Not recorded 
 
Baseline CD4 _ _ % 
Baseline Viral load Log _ , _ _ 




 Not applicable 
Is the child on HAART  No 
 Yes 
 Not recorded 
 Not applicable 
What line  1st 
 2nd 
 3rd 
Duration of HAART in months  
Compliance  No 
 Yes 
 Not recorded 
 Not applicable 
Bactrim prophylaxis  No 
 Yes 
 Not recorded 
 Not applicable 
  
Details of ALRTI:  






























 Influenza A and B 
 Parainfluenza 




 Staph Aureus 
 Strep pneumoniae 
 H. influenzae 





 Mycobacterium TB 
 MOTT 
 
By which test  Blood culture 
 NPA 
 Induced sputum 
 Gastric washing 
 BAL 
Was a nasopharyngeal aspirate done?   No 




Was a BAL done? Results  No 




Was a sputum done? Result  No 




Was a gastric washing done? Result  No 
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Was a blood culture done? Result  No 




Chest radiograph done on admission  No 
 Yes                        Date _ _/_ _/_ _ _ _ 





 Classification of findings:  
 Significant pathology 
 End point consolidation 
 Other infiltrate 
 Pleural effusion 
 
Conclusion of CXR findings: 
 Primary end point pneumonia 
 Other infiltrate 
 No abnormality 
 





 Classification of findings:  
 Significant pathology 
 End point consolidation 
 Other infiltrate 
 Pleural effusion 
 
Conclusion of CXR findings: 
 Primary end point pneumonia 
 Other infiltrate 









 Classification of findings:  
 Significant pathology 
 End point consolidation 
 Other infiltrate 
 Pleural effusion 
 
Conclusion of CXR findings: 
 Primary end point pneumonia 
 Other infiltrate 
 No abnormality 
 
 Not applicable 
  
Management of ALRTI:  
Were antibiotics prescribed?  No 
 Yes                         






 Other                                                                        
Time to first dose in hours  
Were antivirals prescribed?  No 
 Yes                         
Choice of antivirals  Aciclovir 
 Gangciclovir 
 Other                                                                        
Time to first dose in hours  
Were antifungals prescribed?  No 
 Yes                         




Time to first dose in hours 
Was TB treatment started on diagnosis?  No
 Yes
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